Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/9/2025 | Buy → Neutral | BTIG Research | |
| 2/28/2025 | $5.00 → $2.85 | Buy → Hold | Deutsche Bank |
| 8/18/2023 | $15.00 | Buy | BTIG Research |
| 4/21/2023 | $11.00 | Overweight | Cantor Fitzgerald |
| 4/19/2022 | $11.00 | Buy | Deutsche Bank |
| 1/19/2022 | $14.00 | Buy | Stifel |
| 12/21/2021 | $13.00 | Buy | Canaccord Genuity |
| 12/7/2021 | $14.00 | Buy | Needham |
8-K - DocGo Inc. (0001822359) (Filer)
10-Q - DocGo Inc. (0001822359) (Filer)
8-K - DocGo Inc. (0001822359) (Filer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in August and September: Three Part Advisors Midwest (August 26th) Norm Rosenberg, Chief Financial Officer will participate in 1x1 meetings, and deliver a presentation on Tuesday August 26th at 11:30 AM CT. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. Cantor Global Healthcare Conference (September 3rd) Lee Bienstock, Chief Executive Officer will hold 1x1 meetings, and participate in a fireside cha
Company Reiterates 2025 Revenue and Adjusted EBITDA Guidance, Increases Total Cash Balance to $128.7 Million, Signs New Contracts Across All Business Verticals Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Total revenue for the second quarter of 2025 was $80.4 million, compared to $164.9 million in the second quarter of 2024. This decline was due to the planned wind-down of migrant-rel
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced a new contract with one of the largest academic medical systems in the New York metro area. Through this contract, DocGo's dispatchers located within the health system's discharge management office will use DocGo's proprietary transportation management software for centralized management of all discharges across the health system. Through its Ambulnz brand, DocGo will also provide dedicated basic life support (BLS) ambulance services at select facilities. "The consolidated, centralized transportation data offered by DocGo's soft
BTIG Research downgraded DocGo from Buy to Neutral
Deutsche Bank downgraded DocGo from Buy to Hold and set a new price target of $2.85 from $5.00 previously
BTIG Research initiated coverage of DocGo with a rating of Buy and set a new price target of $15.00
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the acquisition of PTI Health, a mid-Atlantic mobile lab collection and phlebotomy services company. This strategic move expands DocGo's healthcare service offering to include mobile phlebotomy lab services, addressing critical gaps in diagnostic care for underserved populations. With this acquisition, DocGo will facilitate timely, convenient blood collection and additional at-home testing services for patients, offering a new level of care to those with limited access to traditional labs or transportation options. The acquisition enhances DocGo's offerings
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the appointment of Stephen K. Klasko, M.D., M.B.A as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024. Dr. Klasko has an extensive background in leadership roles within healthcare, higher education and medical industry innovation, including an eight-year tenure as the President of Thomas Jefferson University and the CEO of Jefferson Health where he oversaw its expansion to 18 hospitals and over 35,000 employees. Prior to that, he was CEO of USF Health and Dean of the Morsani College of Medicine at the University o
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-driven healthcare solutions, is proud to announce Eiwe Lingefors as Chief Information Officer (CIO). Lingefors most recently served as the company's Chief Information Security Officer, and will continue in this role as well. In his new role as CIO, Lingefors will lead both DocGo's information security and digital innovation strategy in an evolving cybersecurity landscape. "Eiwe has been a vital part of our team, and his deep expertise in the security landscape has been instrumental in DocGo's operations," said Lee Bienstock, CEO of DocGo. "He has done an excellent job strengthening DocGo's existing cybers
Company Reiterates 2025 Revenue and Adjusted EBITDA Guidance, Increases Total Cash Balance to $128.7 Million, Signs New Contracts Across All Business Verticals Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Total revenue for the second quarter of 2025 was $80.4 million, compared to $164.9 million in the second quarter of 2024. This decline was due to the planned wind-down of migrant-rel
Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the Company will release its financial results for the second quarter ended June 30, 2025 after the markets close on Thursday, August 7, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, August 7, 2025 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) Conference ID: 75731 To access the Call me™ feature, which avoids the need to w
Company Focuses on Growing Medical Transportation and Payer & Provider Businesses, Navigates Municipal Uncertainty and Migrant Services Transition Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended March 31, 2025. Lee Bienstock, Chief Executive Officer of DocGo, commented, "The impact of ongoing policy changes in Washington and adjustments to public spending on healthcare-related projects have created substantial uncertainty in our Government Populati
SC 13D/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)